000 01634 a2200457 4500
005 20250512103340.0
264 0 _c19741219
008 197412s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(74)90579-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIngebretsen, C
245 0 0 _aEffect of glucagon, dibutyryl adenosine 3',5'-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3',5'-cyclic monophosphate levels.
_h[electronic resource]
260 _bBiochemical pharmacology
_cAug 1974
300 _a2139-46 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBucladesine
_xpharmacology
650 0 4 _aCarboxylic Acids
_xpharmacology
650 0 4 _aCyclic AMP
_xmetabolism
650 0 4 _aGlucagon
_xpharmacology
650 0 4 _aHydrazines
_xpharmacology
650 0 4 _aIn Vitro Techniques
650 0 4 _aKinetics
650 0 4 _aLiver
_xenzymology
650 0 4 _aMale
650 0 4 _aPapaverine
_xpharmacology
650 0 4 _aPhosphodiesterase Inhibitors
650 0 4 _aPhosphoric Diester Hydrolases
_xmetabolism
650 0 4 _aPhosphorylases
_xantagonists & inhibitors
650 0 4 _aPyrazoles
_xpharmacology
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aRats
650 0 4 _aTheophylline
_xpharmacology
650 0 4 _aTime Factors
700 1 _aClark, J F
700 1 _aAllen, D O
700 1 _aAshmore, J
773 0 _tBiochemical pharmacology
_gvol. 23
_gno. 15
_gp. 2139-46
856 4 0 _uhttps://doi.org/10.1016/0006-2952(74)90579-6
_zAvailable from publisher's website
999 _c4374708
_d4374708